Previous Article | Next Article 
Infection and Immunity, September 1998, p. 4522-4525, Vol. 66, No. 9
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Elevated Concentrations of Eotaxin and
Interleukin-5 in Human Neurocysticercosis
Carlton A. W.
Evans,1,
Hector H.
Garcia,2,3
Adele
Hartnell,4
Robert H.
Gilman,2,5,6
Peter J.
Jose,4
Manuel
Martinez,3
Daniel G.
Remick,7
Timothy J.
Williams,4 and
Jon S.
Friedland1,*
Department of Infectious Diseases, Imperial
College School of Medicine, Hammersmith
Hospital,1 and
Department of Applied
Pharmacology, Imperial College School of Medicine, National Heart and
Lung Institute,4 London, United Kingdom;
Department of Microbiology and Pathology, Universidad Cayetano
Heredia,2
Instituto National de
Ciencias Neurologicas,3 and
AB
Prisma,6 Lima, Peru;
Department of
International Health, Johns Hopkins School of Hygiene and Public
Health, Baltimore, Maryland5; and
Department of Pathology, University of Michigan Medical
School, Ann Arbor, Michigan7
Received 23 March 1998/Returned for modification 22 April
1998/Accepted 19 June 1998
Symptomatic neurocysticercosis, a major cause of epilepsy
worldwide, results from inflammation around Taenia solium
larvae, but the mechanisms are unknown. Eotaxin, not previously
reported in cases of human infection, and interleukin-5 (IL-5) but not IL-8 concentrations were elevated in patient serum, and IL-5 levels were also elevated in cerebrospinal fluid (CSF). Eosinophil-selective mediators may be involved in the pathogenesis of cysticercosis. IL-6
concentrations were also elevated in patient CSF, possibly indicative
of an acute-phase response.
*
Corresponding author. Mailing address: Department of
Infectious Diseases, Imperial College, Hammersmith Hospital, Du Cane Road, London W12 0NN, United Kingdom. Phone: 44 181 383 8521. Fax: 44 181 383 3394. E-mail: j.friedland{at}rpms.ac.uk.
Present address: University of Cambridge Clinical School,
Department of Medicine, Addenbrooke's Hospital, Cambridge CB2 2QQ, United Kingdom.
Infection and Immunity, September 1998, p. 4522-4525, Vol. 66, No. 9
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Hartnell, A., Heinemann, A., Conroy, D. M., Wait, R., Sturm, G. J., Caversaccio, M., Jose, P. J., Williams, T. J.
(2004). Identification of Selective Basophil Chemoattractants in Human Nasal Polyps as Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor-2. J. Immunol.
173: 6448-6457
[Abstract]
[Full Text]
-
Singh, G, Kaushal, S, Gupta, M, Chander Chopra, S
(2004). Cutaneous reactions in patients with solitary cysticercus granuloma on phenytoin sodium. J. Neurol. Neurosurg. Psychiatry
75: 331-333
[Abstract]
[Full Text]
-
Cardona, A. E., Gonzalez, P. A., Teale, J. M.
(2003). CC Chemokines Mediate Leukocyte Trafficking into the Central Nervous System during Murine Neurocysticercosis: Role of {gamma}{delta} T Cells in Amplification of the Host Immune Response. Infect. Immun.
71: 2634-2642
[Abstract]
[Full Text]
-
Watanabe, K., Jose, P. J., Rankin, S. M.
(2002). Eotaxin-2 Generation Is Differentially Regulated by Lipopolysaccharide and IL-4 in Monocytes and Macrophages. J. Immunol.
168: 1911-1918
[Abstract]
[Full Text]
-
Culley, F. J., Brown, A., Conroy, D. M., Sabroe, I., Pritchard, D. I., Williams, T. J.
(2000). Eotaxin Is Specifically Cleaved by Hookworm Metalloproteases Preventing Its Action In Vitro and In Vivo. J. Immunol.
165: 6447-6453
[Abstract]
[Full Text]
-
Pal, D. K, Carpio, A., Sander, J. W A S
(2000). Neurocysticercosis and epilepsy in developing countries. J. Neurol. Neurosurg. Psychiatry
68: 137-143
[Abstract]
[Full Text]